2007
DOI: 10.1016/j.eururo.2007.09.039
|View full text |Cite
|
Sign up to set email alerts
|

2007 Guideline for the Management of Ureteral Calculi

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

11
472
2
28

Year Published

2010
2010
2018
2018

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 798 publications
(523 citation statements)
references
References 82 publications
11
472
2
28
Order By: Relevance
“…Calcium channel blockers did not demonstrate a statistically significant improvement in stone passage whereas significantly more (29%; confidence interval [CI] 20%-37%) patients passed their stones with alpha-blocker therapy than did patients receiving a placebo. 4 A Cochrane collaboration meta-analysis demonstrated a higher stone-free rate (RR 1.48, 95% CI 1.33-1.64), a shorter time to stone passage (2.91 days less), with a decreased number of pain episodes, analgesic requirements and hospitalizations for patients with ureteral stones less than 10 mm treated with alpha-receptor antagonists compared to placebo. 8 Conversely, a recent large randomized controlled trial failed to show any benefit from the use of tamsulosin or nifedipine to promote stone passage 9 .…”
Section: Medical Expulsive Therapymentioning
confidence: 99%
See 1 more Smart Citation
“…Calcium channel blockers did not demonstrate a statistically significant improvement in stone passage whereas significantly more (29%; confidence interval [CI] 20%-37%) patients passed their stones with alpha-blocker therapy than did patients receiving a placebo. 4 A Cochrane collaboration meta-analysis demonstrated a higher stone-free rate (RR 1.48, 95% CI 1.33-1.64), a shorter time to stone passage (2.91 days less), with a decreased number of pain episodes, analgesic requirements and hospitalizations for patients with ureteral stones less than 10 mm treated with alpha-receptor antagonists compared to placebo. 8 Conversely, a recent large randomized controlled trial failed to show any benefit from the use of tamsulosin or nifedipine to promote stone passage 9 .…”
Section: Medical Expulsive Therapymentioning
confidence: 99%
“…In 2007 the AUA and EAU joined forces to publish the 2007 Guideline for the Management of Ureteral Calculi, 4 which represented a synthesis of the best available evidence at the time comparing outcomes for SWL to URS. This joint EAU/AUA Nephrolithiasis Guideline Panel performed a systematic review of the English language literature published since 1997 and comprehensively analyzed outcomes data from the identified studies.…”
Section: Comparative Outcomes Of Swl Vs Ursmentioning
confidence: 99%
“…Several studies have demonstrated stone-free rates as follows: renal pelvis 76%, upper calyx 69%, middle calyx 68%, and lower calyx 59%. Stone free rates were dependent on stone burden, with stones < 10 mm allowing excellent stone-free rates [2,22] . SWL success depends on many determinants, such as stone burden, position, composition of the stones, habitus of patient, and the efficacy of the lithotripter.…”
Section: Extracorporeal Swlmentioning
confidence: 99%
“…O manejo de pacientes com cálculos ureterais sintomáticos possui algoritmo validado [29] . No que tange ao tratamento de cálculos assintomáticos, apenas a litíase renal tem protocolos bem estabelecidos [30] .…”
Section: Cálculo Ureteral Silenciosounclassified
“…Idealmente, o USG deve ser associado à radiografia simples de abdome em casos de cálculos radiopacos [29,38] . Já para pacientes que desenvolvem sintomas no pós-operatório, a TC com contraste é recomendada desde que não existam contraindicações.…”
Section: Cálculo Ureteral Silenciosounclassified